Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ginger is the rhizome of the plant Zingiber officinale and has been used for thousands of years in traditional medicine systems such as Chinese and Indian medicine. It contains bioactive compounds like gingerol and shogaol that are responsible for its medicinal properties. Ginger exhibits anti-inflammatory, antioxidant, antimicrobial, and anti-nausea effects. Its primary mechanisms include promoting gastrointestinal motility (helping food move through the digestive tract), reducing nausea (including morning sickness in pregnancy and chemotherapy-induced nausea), alleviating pain (such as menstrual cramps and osteoarthritis), supporting immune function, lowering cholesterol levels, improving insulin sensitivity, reducing bloating/gas/constipation by enhancing digestion, and possibly providing cardiovascular protection. Ginger is consumed fresh or dried as a spice or supplement; it is not regulated as a pharmaceutical drug but widely used as a dietary supplement[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginger.